Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00603876 · ClinicalTrials.gov registry record · Phase 4
Efficacy of Almonds Added to Chronic Statin Therapy
A Phase 4 study, sponsored by University of Kansas.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT00603876 is a Phase 4 study that has completed, run by University of Kansas. The registered enrollment target is 50 participants.
The verdict
NCT00603876, a Phase 4 study, has completed, sponsored by University of Kansas.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the effects of 100-110 grams of almonds (about ¾ cupful) daily on the lipoprotein profile when given to patients on a statin drug. The study will compare the effects on the lipoprotein profile to patients who eat almonds and those patients not eating almonds.
Interventions
- DIETARY_SUPPLEMENT Almonds
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2008-07 |
| Est. Completion | 2012-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00603876
The ClinicalTrials.gov registry entry for NCT00603876 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas, which has 66 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Almonds is the first listed.
NCT00603876 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00603876 about?
NCT00603876 is a clinical study titled "Efficacy of Almonds Added to Chronic Statin Therapy". The purpose of the study is to evaluate the effects of 100-110 grams of almonds (about ¾ cupful) daily on the lipoprotein profile when given to patients on a statin drug. The study will compare the effects on the lipoprotein profile to patients who eat almonds and those patients not eating almonds.
What is the current status of trial NCT00603876?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2008-07. Estimated completion is 2012-12.
What interventions are being tested in trial NCT00603876?
The interventions under investigation include: Almonds (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00603876?
This trial is sponsored by University of Kansas, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.